Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 0NL1.L
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.28 1.65 1.62
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -1171.96 -0.38 -0.03
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.87 6.09 5.86
Cash -6.89 1.13 1.21
Capex inf 0.00 -0.52
Free Cash Flow -10.54 0.36 -0.41
Revenue -15.06 2.82 3.32
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 0.21 0.30 0.30
Operating Margin -20.67 0.12 0.15
ROA -38.91 0.02 0.03
ROE -41.10 0.04 0.06
ROIC -39.49 0.03 0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 0NL1.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 0NL1.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 0NL1.L is permitted for members.